V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER ISSN 1068-1760
Vol. 36 No.5 • 8-9/2019
DAILY CLINICAL LAB NEWS
®
I
N
T
E
Biomarker Test for Chronic Fatigue Syndrome yalgic encephalomyelitis, or chronic fatigue syndrome (ME/CFS), is a serious condition that may affect up to 2.5 million people in the USA. Symptoms include extreme tiredness, difficulty sleeping, trouble with thinking and remembering things, muscle
M
R
N
A
T
I
O
Invasive Pulmonary Aspergillosis Diagnosed by Molecular Test nvasive aspergillosis (IA) is a common opportunistic fungal infection, mainly affecting patients with severe and prolonged neutropenia. Early diagnosis of invasive pulmonary aspergillosis (IPA) is notoriously difficult, but crucial for prompt treatment initi-
I
ation required to improve patient outcome. The mycological evidence used for the diagnosis of probable IPA includes traditional microbiological microscopy and culture of a respiratory specimen, along with non-culture-based serologi-
Cont’d on page 7
Cont’d on page 4
Machine Learning Detects Cancer by Analyzing DNA In Blood Samples
I
R E A D E R
S E R V I C E
bola and Marburg viruses can cause severe bleeding and organ failure, with fatality rates reaching 90% in some outbreaks. The diseases spread through direct contact with bodily fluids of an infected person, monkey, gorilla, chimpanzee or bat. Early symptoms of Ebola and Marburg, include fever, headache and diarrhea, and mimic more common diseases, so there’s a
New Urine Test Could Prevent Cervical Cancer
®
INSIDE
P O R T A L
he strategy of cervical screening depends on reducing the incidence of cervical cancer through the detection and treatment of its precursor lesion, highgrade cervical intraepithelial neoplasia (CIN2+).
T
Renew /Start your Free Subscription Access Interactive Digital Magazine Instant Online Product Information:
Cont’d on page 6
Agilent Expands Immunology Offerings with BioTek Acquisition
Identify LinkXpress codes of 1 interest as you read magazine ®
on LinkXpress.com 2 Click to reach reader service portal
3
Image: Courtesy of iQ Group Global
nderstanding the immunological phenotype of transplant recipients on standard immunosuppression, immune-cell therapies and new drug treatments is essential for improving transplantation outcome. Immune monitoring by multicolor flow cytometry is a highly useful tool to assess the immune response in transplantation, and has the potential to shed insight
U
Cont’d on page 4
T
LINKXPRESS COM
Flow Cytometry Predicts Transplant Rejection
E
See article on page 5
S
L
Simple and Inexpensive Ebola Test Developed
W
I
A
Cont’d on page 6
hile cell-free DNA in the blood provides a noninvasive diagnostic avenue for patients with cancer, characteristics of the origins and molecular features of cell-free DNA are poorly understood. As a remedy, researchers have now developed a machine learning approach to identify abnormal patterns of DNA fragments in the blood of patients.
V
N
Mark code(s) of interest on LinkXpress ® inquiry matrix
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
gilent Technologies Inc., a global leader in the life sciences, diagnostics and applied chemical markets, has signed a definitive agreement to acquire privately-owned BioTek Instruments which designs, manufac-
A
tures, and distributes innovative life science instrumentation. The acquisition of BioTek makes Agilent well positioned in the large and growing immunooncology and immunotherapy markets and expands the company’s Cont’d on page 25
Clinical News . . . . . . 4-20 IFCC News . . . . . . . . . . 21 Product News . . . .10-20 Industry News . . . . . . 25 Events Calendar . . . . . 26 PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<